Dr. Reddys Laboratories Ltd.

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, Dr. Reddy’s Laboratories has informed that it enclosed copies of newspaper advertisement regarding the unaudited financial results of the company for the quarter ended June 30, 2022, as published in Business Standard and Andhra Prabha on July 28, 2022.

The above information is a part of company’s filings submitted to BSE.